Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: Lessons from the PEARL study. Agostinetto E, Ignatiadis M. Ann Oncol 2021 Feb 8. pii: S0923-7534(21)00106.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Agostinetto E, Ignatiadis M. Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: Lessons from the PEARL study. Ann Oncol 2021 Feb 8. pii: S0923-7534(21)00106.
PMID: 33571637